Vaccine Contract Manufacturing Market, By Vaccine Type (Attenuated, Inactivated, DNA-based and Toxoid-based), By Product Type, By Application, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
REPORT HIGHLIGHT
Vaccine Contract Manufacturing Market size was valued at USD 2,900.10 Million in 2023, expanding at a CAGR of 8.00% from 2024 to 2032.
The practice of a pharmaceutical firm (the contract manufacturer) producing vaccines for another corporation, or client, is known as vaccine contract manufacturing. Through this agreement, the client can leverage the contract manufacturer’s expertise, facilities, and capabilities to produce vaccines that meet their specific requirements and standards.
Vaccine Contract Manufacturing Market Dynamics
Rising Demand for Vaccines and Growth in the Biotechnology Industry Expected to Drive Market Expansion
The global demand for vaccines is continually increasing due to expanded vaccination programs, a growing prevalence of infectious diseases, and the necessity for new vaccines to combat emerging pathogens. This growing demand is prompting pharmaceutical companies to seek out contract manufacturing partners who can efficiently scale up production. Vaccine manufacturing often involves specialized facilities, advanced technologies, and expert knowledge. Contract manufacturers with established capabilities in vaccine production offer efficient solutions, allowing pharmaceutical companies to focus on research, development, and distribution. Consequently, advancements in research and technology are playing a crucial role in driving market growth.
Vaccine manufacturing is subject to stringent regulations by health authorities worldwide, including the FDA and EMA. Contract manufacturers with proven expertise in regulatory compliance can accelerate the approval process and ensure adherence to quality standards, thereby reducing the time required to bring new vaccines to market. Additionally, many pharmaceutical companies may encounter limitations in their internal manufacturing capacities. Contract manufacturers provide the necessary additional capacity, flexibility, and scalability to meet varying demands and supply vaccines on a global scale. As a result, vaccine contract manufacturing is crucial in enhancing manufacturing capabilities and supporting market growth in response to evolving demands.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL VACCINE CONTRACT MANUFACTURING MARKET KEY PLAYERS
Lonza Group
Emergent BioSolutions
Catalent
Vaxcyte
Samsung Biologics
Pfizer CentreOne
WuXi Biologics
Boehringer Ingelheim BioXcellence
Fujifilm Diosynth Biotechnologies
AGC Biologics
Rentschler Biopharma
Cytovance Biologics
Grand River Aseptic Manufacturing
KBI Biopharma
Vetter Pharma
Ajinomoto Co Inc.
CMC Biologics
Others
GLOBAL VACCINE CONTRACT MANUFACTURING MARKET, BY VACCINE TYPE- MARKET ANALYSIS, 2019-2032
Attenuated
Inactivated
DNA-based
Toxoid-based
GLOBAL VACCINE CONTRACT MANUFACTURING MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019-2032
Single vaccine
Combination vaccine
GLOBAL VACCINE CONTRACT MANUFACTURING MARKET, BY APPLICATION- MARKET ANALYSIS, 2019-2032
Human Use
Veterinary
GLOBAL VACCINE CONTRACT MANUFACTURING MARKET, BY END USER- MARKET ANALYSIS, 2019-2032
Biopharmaceutical Companies
Research Laboratories
Others
GLOBAL VACCINE CONTRACT MANUFACTURING MARKET, BY REGION- MARKET ANALYSIS, 2019-2032
North America
o The U.S.
o Canada
Europe
o Germany
o France
o Italy
o Spain
o United Kingdom
o Russia
o Netherlands
o Sweden
o Poland
o Rest of Europe
Asia Pacific
o India
o China
o South Korea
o Japan
o Australia
o Thailand
o Indonesia
o Philippines
o Rest of APAC
Latin America
o Brazil
o Mexico
o Argentina
o Colombia
o Rest of LATAM
The Middle East and Africa
o Saudi Arabia
o United Arab Emirates
o Israel
o Turkey
o Algeria
o Egypt
o Rest of MEA
TABLE OF CONTENT
1. Vaccine Contract Manufacturing Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Vaccine Contract Manufacturing Market Snippet by Vaccine Type
2.1.2. Vaccine Contract Manufacturing Market Snippet by Product Type
2.1.3. Vaccine Contract Manufacturing Market Snippet by Application
2.1.4. Vaccine Contract Manufacturing Market Snippet by End User
2.1.5. Vaccine Contract Manufacturing Market Snippet by Country
2.1.6. Vaccine Contract Manufacturing Market Snippet by Region
2.2. Competitive Insights
3. Vaccine Contract Manufacturing Key Market Trends
3.1. Vaccine Contract Manufacturing Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Vaccine Contract Manufacturing Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Vaccine Contract Manufacturing Market Opportunities
3.4. Vaccine Contract Manufacturing Market Future Trends
4. Vaccine Contract Manufacturing Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Vaccine Contract Manufacturing Market: COVID-19 Impact Analysis
5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
5.2.1. Top Performing Segments
5.2.2. Marginal Growth Segments
5.2.3. Top Looser Segments
5.2.4. Marginal Loss Segments
6. Vaccine Contract Manufacturing Market Landscape
6.1. Vaccine Contract Manufacturing Market Share Analysis, 2023
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Vaccine Contract Manufacturing Market – By Vaccine Type
7.1. Overview
7.1.1. Segment Share Analysis, By Vaccine Type, 2024 & 2032 (%)
7.1.2. Attenuated
7.1.3. Inactivated
7.1.4. DNA-based
7.1.5. Toxoid-based
8. Vaccine Contract Manufacturing Market – By Product Type
8.1. Overview
8.1.1. Segment Share Analysis, By Product Type, 2024 & 2032 (%)
8.1.2. Single vaccine
8.1.3. Combination vaccine
9. Vaccine Contract Manufacturing Market – By Application
9.1. Overview
9.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
9.1.2. Human Use
9.1.3. Veterinary
10. Vaccine Contract Manufacturing Market – By End User
10.1. Overview
10.1.1. Segment Share Analysis, By End User, 2024 & 2032 (%)
10.1.2. Biopharmaceutical Companies
10.1.3. Research Laboratories
10.1.4. Others
11. Vaccine Contract Manufacturing Market– By Geography
11.1. Introduction
11.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
11.2. North America
11.2.1. Overview
11.2.2. Vaccine Contract Manufacturing Key Manufacturers in North America
11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.2.4. North America Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
11.2.5. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.2.6. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.2.7. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.2.8. U.S.
11.2.8.1. Overview
11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.2.8.3. U.S. Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
11.2.8.4. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.2.8.5. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.2.8.6. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.2.9. Canada
11.2.9.1. Overview
11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.2.9.3. Canada Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
11.2.9.4. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.2.9.5. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.2.9.6. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.3. Europe
11.3.1. Overview
11.3.2. Vaccine Contract Manufacturing Key Manufacturers in Europe
11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.3.4. Europe Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
11.3.5. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.3.6. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.7. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.3.8. Germany
11.3.8.1. Overview
11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.3.8.3. Germany Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
11.3.8.4. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.3.8.5. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.8.6. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.3.9. Italy
11.3.9.1. Overview
11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.3.9.3. Italy Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
11.3.9.4. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.3.9.5. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.9.6. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.3.10. United Kingdom
11.3.10.1. Overview
11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.3.10.3. United Kingdom Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
11.3.10.4. United Kingdom Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.3.10.5. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.10.6. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.3.11. France
11.3.11.1. Overview
11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.3.11.3. France Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
11.3.11.4. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.3.11.5. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.11.6. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.3.12. Russia
11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.3.12.2. Russia Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
11.3.12.3. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.3.12.4. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.12.5. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.3.13. Netherlands
11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.3.13.2. Netherlands Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
11.3.13.3. Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.3.13.4. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.13.5. Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.3.14. Sweden
11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.3.14.2. Sweden Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
11.3.14.3. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.3.14.4. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.14.5. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.3.15. Poland
11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.3.15.2. Poland Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
11.3.15.3. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.3.15.4. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.15.5. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.3.16. Rest of Europe
11.3.16.1. Overview
11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.3.16.3. Rest of the Europe Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
11.3.16.4. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.3.16.5. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.16.6. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.4. Asia Pacific (APAC)
11.4.1. Overview
11.4.2. Vaccine Contract Manufacturing Key Manufacturers in Asia Pacific
11.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.4.4. Asia Pacific Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
11.4.5. Asia Pacific Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.4.6. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.7. Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.4.8. India
11.4.8.1. Overview
11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.4.8.3. India Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
11.4.8.4. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.4.8.5. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.8.6. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.4.9. China
11.4.9.1. Overview
11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.4.9.3. China Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
11.4.9.4. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.4.9.5. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.9.6. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.4.10. Japan
11.4.10.1. Overview
11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.4.10.3. Japan Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
11.4.10.4. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.4.10.5. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.10.6. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.4.11. South Korea
11.4.11.1. Overview
11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.4.11.3. South Korea Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
11.4.11.4. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.4.11.5. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.11.6. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.4.12. Australia
11.4.12.1. Overview
11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.4.12.3. Australia Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
11.4.12.4. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.4.12.5. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.12.6. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.4.13. Thailand
11.4.13.1. Overview
11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.4.13.3. Thailand Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
11.4.13.4. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.4.13.5. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.13.6. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.4.14. Indonesia
11.4.14.1. Overview
11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.4.14.3. Indonesia Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
11.4.14.4. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.4.14.5. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.14.6. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.4.15. Philippines
11.4.15.1. Overview
11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.4.15.3. Philippines Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
11.4.15.4. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.4.15.5. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.15.6. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.4.16. Rest of APAC
11.4.16.1. Overview
11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.4.16.3. Rest of APAC Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
11.4.16.4. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.4.16.5. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.16.6. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.5. Latin America
11.5.1. Overview
11.5.2. Vaccine Contract Manufacturing Key Manufacturers in Latin America
11.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.5.4. Latin America Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
11.5.5. Latin America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.5.6. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.5.7. Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.5.8. Brazil
11.5.8.1. Overview
11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.5.8.3. Brazil Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
11.5.8.4. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.5.8.5. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.5.8.6. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.5.9. Mexico
11.5.9.1. Overview
11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.5.9.3. Mexico Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
11.5.9.4. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.5.9.5. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.5.9.6. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.5.10. Argentina
11.5.10.1. Overview
11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.5.10.3. Argentina Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
11.5.10.4. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.5.10.5. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.5.10.6. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.5.11. Colombia
11.5.11.1. Overview
11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.5.11.3. Colombia Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
11.5.11.4. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.5.11.5. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.5.11.6. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.5.12. Rest of LATAM
11.5.12.1. Overview
11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.5.12.3. Rest of LATAM Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
11.5.12.4. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.5.12.5. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.5.12.6. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.6. Middle East and Africa
11.6.1. Overview
11.6.2. Vaccine Contract Manufacturing Key Manufacturers in Middle East and Africa
11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.6.4. Middle East and Africa Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
11.6.5. Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.6.6. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.7. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.6.8. Saudi Arabia
11.6.8.1. Overview
11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.6.8.3. Saudi Arabia Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
11.6.8.4. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.6.8.5. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.8.6. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.6.9. United Arab Emirates
11.6.9.1. Overview
11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.6.9.3. United Arab Emirates Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
11.6.9.4. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.6.9.5. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.9.6. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.6.10. Israel
11.6.10.1. Overview
11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.6.10.3. Israel Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
11.6.10.4. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.6.10.5. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.10.6. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.6.11. Turkey
11.6.11.1. Overview
11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.6.11.3. Turkey Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
11.6.11.4. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.6.11.5. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.11.6. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.6.12. Algeria
11.6.12.1. Overview
11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.6.12.3. Algeria Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
11.6.12.4. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.6.12.5. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.12.6. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.6.13. Egypt
11.6.13.1. Overview
11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.6.13.3. Egypt Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
11.6.13.4. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.6.13.5. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.13.6. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.6.14. Rest of MEA
11.6.14.1. Overview
11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.6.14.3. Rest of MEA Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
11.6.14.4. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
11.6.14.5. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.14.6. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12. Key Vendor Analysis- Vaccine Contract Manufacturing Industry
12.1. Competitive Dashboard
12.2. Company Profiles
12.2.1. Lonza Group
12.2.2. Emergent BioSolutions
12.2.3. Catalent
12.2.4. Vaxcyte
12.2.5. Samsung Biologics
12.2.6. Pfizer CentreOne
12.2.7. WuXi Biologics
12.2.8. Boehringer Ingelheim BioXcellence
12.2.9. Fujifilm Diosynth Biotechnologies
12.2.10. AGC Biologics
12.2.11. Rentschler Biopharma
12.2.12. Cytovance Biologics
12.2.13. Grand River Aseptic Manufacturing
12.2.14. KBI Biopharma
12.2.15. Vetter Pharma
12.2.16. Ajinomoto Co Inc.
12.2.17. CMC Biologics
12.2.18. Others
13. 360 Degree Analyst View
14. Appendix
14.1. Research Methodology
14.2. References
14.3. Abbreviations
14.4. Disclaimer
14.5. Contact Us
